<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Low density lipoprotein cholesterol (LDL-C) lowering with drugs in patients with cardiovascular disease (secondary prevention)*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Low density lipoprotein cholesterol (LDL-C) lowering with drugs in patients with cardiovascular disease (secondary prevention)*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Low density lipoprotein cholesterol (LDL-C) lowering with drugs in patients with cardiovascular disease (secondary prevention)*</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes">* Secondary prevention patients include those with coronary artery carotid, aorta, or peripheral artery disease.<br/>¶ In some cases it may be appropriate to start at a lower dose and uptitrate.<br/>Δ The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary. "Significant" will vary from patient to patient and depends on many factors such as overall cardiovascular risk, likely compliance with a recommendation for additional therapy, or co-morbidities. Refer to relevant UpToDate topic reviews.<br/>◊ High-risk secondary prevention patients include those with acute coronary syndrome in the past year, familial hypercholesterolemia, diabetes, chronic kidney disease (stage 3 or 4), repeat atherosclerotic cardiovascular disease event, or the need for revascularization while on statin.<br/></div><div id="graphicVersion">Graphic 114470 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
